Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Beta-blocker crossover CO2 challenge study on peripheral and central contributions to panic experience
NL-OMON49383Active, not recruiting
- Sponsor
- Amsterdam University Medical Center
- Start
- Feb 2021
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Randomised trial comparing Atenolol sequence condition, Metoprolol sequence condition and Placebo sequence condition (3 arms). Primary endpoints: Change in fear rating, Change in discomfort rating and 1 more. Started Feb 2021; status: active, not recruiting.
02
Drugs
atenololmetoprolol
Beyond the preview
Go deeper on NL-OMON49383.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NL-OMON49383.